Kudos to Billy10us International Pharmas doing clinical

New Post Public Reply Private Reply Replies (0) Message Board
Fit007
817
Kudos to Billy10us

International Pharmas doing clinical trials in Russia. Putin won't and nor does he want to prematurely obtain early trial results on B, or any other drug for that matter, being conducted in Russia. Why? Because clinical trials being conducted there will be a cash cow for Russia for decades to come once they are established a safe and bonafide player. Economically speaking Russia is in decline and has been faltering badly for years. Revenues from crude oil has been declining dramatically from years gone by. Global pharmaceutical companies are now using them for clinical trials of their pipeline drugs. Their safety record and efficiency has been verified as being better that our own system of clinical trials in the US and that is also is true of the EU system.
And what International Pharmas are testing in Russia:
1. Merck(USA) 4 studies 500 subjects
2. Novartis(Switz.) 4 studies 77 subjects
3. Interun Therapeutics (Ireland) 3 studies 466 subjects
4.Acadia Pharm. (USA) 3 studies 158 subjects
5.Minerva Pharm.(Greece) 2 studies 380 subjects
6.Rompharm (Romania) 2 studies subjects 330
7.Sentis Pharma (India) 2 studies subjects 264
8.Janssen(J&J) 2 studies subjects 160
9.AstraZenica(UK-Swedish) 2 studies subjects 128
10.Novo Nordisc(Denmark) 2 studies subjects 118
https://across.global/wp-content/uploads/2020...2019Q1.pdf

Their costs of running trials are significantly cheaper than conducting them in the USA and the EU countries. Putin is ruthless, but he is a very smart man. He would not jeopardize the fledgling Clinical Trials industry that would become a major player on the world stage if he stepped in prematurely. He will wait with the rest of us for the proper protocols of releasing trial data. Additionally, the FDA and Europe's equivalent are on site in Russia overseeing the trials of American Pharmas. The FDA's oversight and the EU equivalent monitoring is what has given Russia the accolades and reason that worldwide Pharmas trust their Clinical Trial System. But that's just my opinion. IMO it was genius that Leo had the insight and foresight to utilize the Russian Clinical Trials system.
And to refute the argument that their vaccine (Sputnik) that Russia administered for its people is lacking efficacy or failed efficacy proves nothing. Their vaccine most likely went through a complete different trial scrutiny from the Clinical Trial system in place and Putin most likely had input on their vaccine. The drugs that US & EU Pharmas go through in Russia and the on site oversight that the FDA requires for verification of the proper protocols for phase 1,2,3 went through a much more vigorous protocols with international oversight at the venue sites where drugs were given for the different phase studies.
https://credevo.com/articles/2018/07/30/russi...y-process/

And it will be the success in Russia that will protect IPIX and B from being buried by Big Pharma and lobbyists here from reaching it’s true capabilities. BP can’t keep that enigmatic cat in the bag for much longer. IPIX will shine and prosper for all us longs and more importantly will save millions of lives from suffering and deaths to individuals and their families. For me financial remuneration will just be the icing on the cake. I welcome intelligent and thoughtful discourse.

Innovation Pharmaceuticals Inc (IPIX) Stock Research Links

IPIX Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

ALS Research Gains Momentum as ACT for ALS Law Signed

Updated Category News Views 36

A Major Stride in ALS Advocacy Today's not your usual day at the office for the folks championing the fight against ALS. With the President putting pen to paper, the ACT for ALS Act just turned into law, sending ripples through the community. Let me tell ya, legislation like this doesn't float by on a cloud—it's the result of grit, sleepless nights, and a dash of...

Continue Reading
SportsMed Expands to 58 Clinics, New Opening in Jersey City

Updated Category News Views 33

SportsMed Physical Therapy Expands with New Clinic Well, here we are, talking about expansion. And not just any expansion—I'm talking about SportsMed Physical Therapy flexing its muscles in Jersey City Heights, boosting their count to 58 clinics scattered across New Jersey and Connecticut. It's like watching a network of care roots spreading deeper into the region, and...

Continue Reading
Quarterhill's Q3 2026 Call Teases Insight into ITS Growth

Updated Category News Views 19

The clock's ticking down to November 10, and eyes are peeled for Quarterhill's Q3 financial debrief. Why the fuss? Well, they’ve made quite a name for themselves in the Intelligent Transportation System (ITS) scene, tossing AI into the mix to boot. If you’re playing in this space—or just sneaking a peek to see where tech’s steering us next—you might want to dial...

Continue Reading
Japan's RWE Market Transformation: TXP's Insightful Whitepaper

Updated Category News Views 10

Unraveling the Real-World Evidence Landscape in Japan The folks at TXP Medical just dropped a bombshell of a whitepaper that'll have Medical Affairs departments buzzing. Imagine waking up to a market that's exploding by over 500% in just a decade—yeah, I'm talking about the EMR-derived data market in Japan. These guys are saying it's gonna shoot from ¥3.9 billion in...

Continue Reading
PRIMA Invests £10M to Propel CC Forum's Global Reach

Updated Category News Views 98

Strategic Commitment for Global Impact You've got to hand it to these folks—they're on a mission to roll up their sleeves and tackle climate change head-on. Max Studennikoff, the brains behind CC Forum, just inked a Letter of Intent with Alexander Zhardanovsky, founder of PRIMA, punctuated by an eye-popping £10 million pledge. It's all about boosting the Forum’s...

Continue Reading
WhiteFiber: Expanding North Carolina Data Center Capacity

Updated Category News Views 20

WhiteFiber's Strategic Leap in North Carolina When a company starts throwing millions around, you better perk your ears up. WhiteFiber's $60 million plunge into North Carolina's dirt has filled their cart with two hefty data center projects. They're not messing around—just look at that cash down, with NASDAQ:WYFI betting big on these Yadkin County sites. Smart move or...

Continue Reading
Cambiotics Launches Key Trial on Reducing PFAS in Firefighters

Updated Category News Views 68

Pioneering Efforts to Combat 'Forever Chemicals' Cambiotics is stepping into some uncharted territory—tackling the tricky problem of PFAS accumulation in firefighters. If you’ve been following this, PFAS, or per- and polyfluoroalkyl substances, have been living rent-free in our bodies for years. Used in firefighting equipment and foams, these chemicals stick around,...

Continue Reading
FileInvite Transforms Complex Lending with Bold Platform Relaunch

Updated Category News Views 52

A New Era for Lending Documentation If you've been drumming your fingers waiting on loan paperwork to get sorted, FileInvite's latest move might just be the caffeine kick the lending world needs. Announced at the NAGGL Annual Conference, their souped-up platform has been redesigned as the beating heart of lending documentation. This isn't just a facelift folks—it's an...

Continue Reading
Tigo Energy Faces Class Action: Investor Implications

Updated Category News Views 46

Ah, here we go again, folks. Another day, another stock horror story. This time it’s Tigo Energy, Inc. (NASDAQ:TYGO) struggling under the microscope of a securities class action, care of the Law Offices of Howard G. Smith. If you’ve been keeping an eye on this one, buckle up—it's quite the mess. The Situation at Tigo Energy First off, let’s talk numbers. Tigo...

Continue Reading
Cerbo's AI Scribe Expands to Telehealth Success

Updated Category News Views 78

Cerbo Enhances Telehealth With AI Scribe Expansion The digital healthcare playground looks like it's getting a nudge toward efficiency with Cerbo's latest move. Just when you thought telehealth couldn't get much sharper, these folks have drawn a line in the sand with their AI Scribe, which now makes its presence felt in virtual visits. No more juggling a dozen screens...

Continue Reading

Top 5 Most Recently Viewed Articles

AbbVie Reports Encouraging Findings from TEMPO-2 Trial

Updated Category News Views 248

AbbVie Reports Positive Results from the Phase 3 TEMPO-2 Trial AbbVie (NYSE: ABBV) has made significant strides in the treatment of Parkinson's disease with its investigational drug, tavapadon. Recent findings from the pivotal Phase 3 TEMPO-2 trial have brought forth encouraging news for those affected by this challenging condition. Tavapadon demonstrated a notable...

Continue Reading
Understanding Recent Trends in Honda Motor Co's Stock Interest

Updated Category News Views 101

Trends in Short Interest for Honda Motor Co Honda Motor Co's short percent of float has recently dropped by 8.57%, according to the latest reporting. Currently, there are 4.27 million shares sold short, which accounts for 0.32% of all available shares. Considering the trading volume, it would typically require around 4.71 days for traders to cover their short positions on...

Continue Reading
HMH Distributes Historic Artwork to Northeast Museums

Updated Category News Views 88

A Treasure Chest of Art Finds New Homes When it comes to donating art, HMH isn't just about flipping a few pages of history; they're turning whole chapters. HMH, with a legacy stretching back centuries in the heartland of Boston, decided to part ways with 20 pieces of iconic art, spreading cultural seeds across some prominent northeastern museums. These aren't just any...

Continue Reading
Kasm Technologies Unveils Major Update to Workspaces Platform

Updated Category News Views 369

Exciting New Features in Kasm Workspaces v1.16 Kasm Technologies has introduced significant upgrades with the launch of Kasm Workspaces v1.16, enhancing its remote workplace streaming platform. This version integrates Kubernetes support, a Managed Egress feature, and an RDP Gateway, ensuring a more robust and secure user experience. Improved Remote Work Capabilities With...

Continue Reading
GoldQuest Mining Corp. Joins OTCQX: A Milestone Achievement

Updated Category News Views 138

GoldQuest Mining Corp. Upgrades to OTCQX This significant upgrade allows GoldQuest Mining Corp. (OTC: GDQMF) to access a broader spectrum of U.S. investors and enhance its market presence. By transitioning from the Pink Limited Market to the OTCQX Best Market, the company is aligned with higher financial standards and corporate governance practices. CEO’s Insight on...

Continue Reading